Home > Insider Trading > Filing (0001127602-21-004269)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1761920	T Bryan Baldasare	3471 River Hills Drive Cincinnati OH 45244	Exec Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-05	11,250	$19.56	72,882	No	4	M	Direct
Common Stock	Disposition	2021-02-05	14,250	$26.61	58,632	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2021-02-05	11,250	$0.00	11,250	$19.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,750		2026-03-24	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
Prices range from $25.00 per share to $29.00 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020.